| A2. Methodological Quality Questionnaire Internal validity | |
| 1. Was the assigned treatment adequately concealed prior to allocation? | X1 |
| 2. Were the outcomes of patients who withdrew or were excluded after allocation described and included in an intention to treat analysis? | X2 |
| 3. Were the outcome assessors blind to assignment status? | X3 |
| 4. Were the participants blind to assignment status following allocation? | X4 |
| 5. Were the treatment providers blind to assignment status? | X5 |
| 6. Were the care programs, other than the trial options, identical? | X6 |
| 7. Were the withdrawals <10% of the trial population? | X7 |
| External validity | |
| 1. Were the inclusion and exclusion criteria for entry clearly defined? | X8 |
| 2. Were the outcome measures used clearly defined? | X9 |
| 3. Were accuracy, precision, observer variation of measures adequate? | X10 |
| 4. Was the timing of the outcome measures appropriate? | X11 |
| 5. The quality of allocation concealment was graded? | X12 |
| Statistical validity | |
| 1. Was the main endpoint mentioned? | X13 |
| 2. Was the power analysis described? | X14 |
| 3. Baseline comparison reported? | X15 |
| 4. Statistical technique appropriate? | X16 |
| 5. Table and graphical results clear? | X17 |